PLSE - Truly amazing run given the FDA issues. 10Q has section and comments about FDA risk but not much more offered on what soft tissue data the FDA asked for that caused prior management to withdrawal application. Duggan has replaced completely the prior management since. He now owns 36% of company. Is that the only reason the stock has rocketed from his $15 purchase price? Low float and illiquid options makes this highly volatile but I may give it a shot.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.